Despite recommendations, patients with treatment-resistant hypertension rarely tested for primary al

(American College of Physicians) A retrospective cohort study found that testing for primary aldosteronism in patients with treatment-resistent hypertension was rare and also associated with higher rates of evidence-based treatment and better longitudinal blood pressure control. The findings are published in Annals of Internal Medicine.